| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.39 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.03 |